[1]
Gupta, V.K., Pannu, D., Singh, M.P. and Kumar, L. 2023. Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas. International Journal of Advances in Medicine. 10, 6 (May 2023), 446–451. DOI:https://doi.org/10.18203/2349-3933.ijam20231450.